blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2036894

EP2036894 - AURORA INHIBITOR [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  26.10.2012
Database last updated on 31.08.2024
Most recent event   Tooltip26.10.2012Application deemed to be withdrawnpublished on 28.11.2012  [2012/48]
Applicant(s)For all designated states
Kyowa Hakko Kirin Co., Ltd.
1-6-1, Ohtemachi Chiyoda-ku
Tokyo 100-8185 / JP
[2009/12]
Inventor(s)01 / SHIOTSU, Yukimasa
Drug DiscoveryResrch Lab.Kyowa Hakko Kirin Co.Ltd
1188, Shimotogari, Nagaizumi-cho Sunto-gun, Shizuoka 411-8731 / JP
02 / ISHII, Kenichi
Drug DiscoveryResrch Lab.Kyowa Hakko Kirin Co.Ltd
1188, Shimotogari, Nagaizumi-cho Sunto-gun, Shizuoka 411-8731 / JP
03 / UMEHARA, Hiroshi
Drug DiscoveryResrch Lab.Kyowa Hakko Kirin Co.Ltd
1188, Shimotogari, Nagaizumi-cho Sunto-gun, Shizuoka 411-8731 / JP
 [2009/12]
Representative(s)Harding, Charles Thomas, et al
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
[N/P]
Former [2009/12]Harding, Charles Thomas, et al
D Young & Co 120 Holborn
London EC1N 2DY / GB
Application number, filing date07767883.729.06.2007
[2009/12]
WO2007JP63096
Priority number, dateJP2006018053130.06.2006         Original published format: JP 2006180531
[2009/12]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008001886
Date:03.01.2008
Language:JA
[2008/01]
Type: A1 Application with search report 
No.:EP2036894
Date:18.03.2009
Language:EN
[2009/12]
Search report(s)International search report - published on:JP03.01.2008
(Supplementary) European search report - dispatched on:EP13.12.2010
ClassificationIPC:C07D231/56, A61K31/416, A61K31/4439, A61K31/454, A61K31/496, A61K31/5377, A61P35/00, A61P35/02, A61P43/00, C07D401/06, C07D403/10
[2009/12]
CPC:
C07D403/10 (EP,US); A61K31/416 (EP,US); A61K31/4439 (EP,US);
A61K31/454 (EP,US); A61K31/496 (EP,US); A61K31/5377 (EP,US);
A61P35/00 (EP); A61P35/02 (EP); A61P43/00 (EP);
C07D231/56 (EP,US); C07D401/06 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/12]
TitleGerman:AURORA-INHIBITOR[2009/12]
English:AURORA INHIBITOR[2009/12]
French:INHIBITEUR D'AURORA[2009/12]
Entry into regional phase15.01.2009Translation filed 
16.01.2009National basic fee paid 
16.01.2009Search fee paid 
16.01.2009Designation fee(s) paid 
16.01.2009Examination fee paid 
Examination procedure16.01.2009Examination requested  [2009/12]
08.07.2011Amendment by applicant (claims and/or description)
12.01.2012Despatch of a communication from the examining division (Time limit: M04)
23.05.2012Application deemed to be withdrawn, date of legal effect  [2012/48]
28.06.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2012/48]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  12.01.2012
Fees paidRenewal fee
16.06.2009Renewal fee patent year 03
28.06.2010Renewal fee patent year 04
21.06.2011Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
30.06.201206   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]EP1650194  (KYOWA HAKKO KOGYO KK [JP]) [X] 1-32 * p. 23, table 6; p. 22, table 5; p. 15, compounds table 1; table 4; claims 17, 18 *;
 [X]EP1652842  (KYOWA HAKKO KOGYO KK [JP]) [X] 1-32 * table 2; compounds table 1; claims 1, 21, 22, 24 *;
 [E]EP1847532  (KYOWA HAKKO KOGYO KK [JP]) [E] 1-32* claims; test example 1, table 9 §0057; p.12, l. 1-11 *
International search[X]JPH0232059  (KYOWA HAKKO KOGYO KK);
 [A]JP2004517894  ;
 [A]US2005009876  (BHAGWAT SHRIPAD S [US], et al);
 [X]WO2005012257  (KYOWA HAKKO KOGYO KK [JP], et al);
 [X]WO2005012258  (KYOWA HAKKO KOGYO KK [JP], et al);
 [A]JP2005507922  ;
 [A]JP2005512967  ;
 [A]JP2005534635  ;
 [XP]WO2006080450  (KYOWA HAKKO KOGYO KK [JP], et al);
 [XP]WO2006118257  (KYOWA HAKKO KOGYO KK [JP], et al);
 [XP]JP2007051082  (KYOWA HAKKO KOGYO KK);
 [XP]WO2007056075  (TARGEGEN INC [US], et al);
 [XP]WO2007058626  (S BIO PTE LTD [SG], et al);
 [A]  - MORTLOCK A. ET AL., "Progress in the development of selective inhibitors of Aurora kinases", CURRENT TOPICS IN MEDICINAL CHEMISTRY, (200504), vol. 5, no. 2, pages 199 - 213, XP009057206

DOI:   http://dx.doi.org/10.2174/1568026053507651
by applicantJPH0232059
 WO0102369
 WO0121596
 WO0153268
 WO0210137
 WO02083648
 US2003069299
 WO03101968
 WO2004050088
 WO2004094388
 WO2005012257
 WO2005012258
 US2005137171
 WO2005094823
    - TRENDS IN CELL BIOLOGY, (1999), vol. 9, page 454
    - BRITISH JOURNAL OF CANCER, (2001), vol. 84, page 824
    - JOURNAL OF NATIONAL CANCER INSTITUTE, (2002), vol. 94, page 1320
    - AURORA A, ONCOGENE, (1997), vol. 14, page 2195
    - EMBO JOURNAL, (1998), vol. 17, page 3052
    - THE JOURNAL OF BIOLOGICAL CHEMISTRY, (1999), vol. 274, page 7334
    - HESPERADIN, THE JOURNAL OF CELL BIOLOGY, (2003), vol. 161, page 281
    - THE JOURNAL OF CELL BIOLOGY, (2003), vol. 161, page 267
    - NATURE REVIEW CANCER, (2004), vol. 4, page 927
    - NATURE MEDICINE, (2004), vol. 3, page 262
    - KHIMIYA GETEROTSIKLICHESKIKH SOEDINENII, (1978), vol. 7, pages 957 - 959
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.